1600 Grand Ave
St. Paul MN 55105
2007 Distinguished Citizen Award
For almost 40 years, Genell Knatterud has been one of the country’s leading practitioners of and advocates for clinical trials. She has served as the principal investigator or co-investigator for 10 long-term, multi-center trials supported by the National Institutes of Health and for eight trials supported by drug company sponsors.
Knatterud led the statistical centers for several groundbreaking trials, including the University Group Diabetes Program, the Diabetic Retinopathy Study, the Post-Coronary Artery Bypass Graft Study and the Occluded Artery Trial. She has frequently served on Federal Advisory Committees and on advisory boards for highly significant trials, including those of the Women’s Health Initiative of the National Institutes of Health. Her work has been published more than 175 times in medical journals including the Journal of the American Medical Association and the New England Journal of Medicine. Most recently, she chaired the boards of Maryland Medical Research Institute and Clinical Trials & Surveys Corporation in Baltimore.
Knatterud earned her Ph.D. in biometry at the University of Minnesota in 1963 and has, in turn, been devoted to preparing the next generation of biostatisticians, serving as professor, then acting director, of clinical investigation at the University of Maryland from 1973 to 1984. More recently, she held an adjunct appointment at the University of Maryland and a visiting appointment at Johns Hopkins University School of Hygiene and Public Health.
In May 2006, the Society for Clinical Trials named the celebrated researcher an inaugural Fellow of the Society, honoring her as "leader of several groundbreaking trials, beloved mentor, past member of the Society’s Board of Directors and past president of the Society, Genell Knatterud."